vs

Side-by-side financial comparison of Information Services Group Inc. (III) and PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB). Click either name above to swap in a different company.

Information Services Group Inc. is the larger business by last-quarter revenue ($61.2M vs $44.6M, roughly 1.4× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Information Services Group Inc. runs the higher net margin — 4.3% vs -90.4%, a 94.7% gap on every dollar of revenue. On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs 5.9%). Information Services Group Inc. produced more free cash flow last quarter ($4.3M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -2.4%).

EBSCO Information Services, headquartered in Ipswich, Massachusetts, is a division of EBSCO Industries Inc., a private company headquartered in Birmingham, Alabama. EBSCO provides products and services to libraries of many types around the world. Its products include EBSCONET, a complete e-resource management system, and EBSCOhost, which supplies a fee-based online research service with 375 full-text databases, a collection of 600,000-plus ebooks, subject indexes, point-of-care medical refere...

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

III vs PACB — Head-to-Head

Bigger by revenue
III
III
1.4× larger
III
$61.2M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+7.9% gap
PACB
13.8%
5.9%
III
Higher net margin
III
III
94.7% more per $
III
4.3%
-90.4%
PACB
More free cash flow
III
III
$24.2M more FCF
III
$4.3M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-2.4%
III

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
III
III
PACB
PACB
Revenue
$61.2M
$44.6M
Net Profit
$2.6M
$-40.4M
Gross Margin
44.8%
37.1%
Operating Margin
8.4%
-92.3%
Net Margin
4.3%
-90.4%
Revenue YoY
5.9%
13.8%
Net Profit YoY
-14.1%
-1802.7%
EPS (diluted)
$0.06
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
III
III
PACB
PACB
Q4 25
$61.2M
$44.6M
Q3 25
$62.4M
$38.4M
Q2 25
$61.6M
$39.8M
Q1 25
$59.6M
$37.2M
Q4 24
$57.8M
$39.2M
Q3 24
$61.3M
$40.0M
Q2 24
$64.3M
$36.0M
Q1 24
$64.3M
$38.8M
Net Profit
III
III
PACB
PACB
Q4 25
$2.6M
$-40.4M
Q3 25
$3.1M
$-38.0M
Q2 25
$2.2M
$-41.9M
Q1 25
$1.5M
$-426.1M
Q4 24
$3.0M
$2.4M
Q3 24
$1.1M
$-60.7M
Q2 24
$2.0M
$-173.3M
Q1 24
$-3.4M
$-78.2M
Gross Margin
III
III
PACB
PACB
Q4 25
44.8%
37.1%
Q3 25
42.2%
41.4%
Q2 25
42.2%
36.9%
Q1 25
43.1%
-3.7%
Q4 24
41.5%
25.6%
Q3 24
40.4%
25.0%
Q2 24
39.5%
16.5%
Q1 24
36.1%
29.1%
Operating Margin
III
III
PACB
PACB
Q4 25
8.4%
-92.3%
Q3 25
7.4%
-101.1%
Q2 25
7.6%
-112.8%
Q1 25
5.7%
-1154.5%
Q4 24
0.3%
-390.1%
Q3 24
7.0%
-160.3%
Q2 24
5.7%
-488.3%
Q1 24
-3.7%
-209.6%
Net Margin
III
III
PACB
PACB
Q4 25
4.3%
-90.4%
Q3 25
4.9%
-98.9%
Q2 25
3.5%
-105.4%
Q1 25
2.5%
-1146.8%
Q4 24
5.3%
6.0%
Q3 24
1.9%
-151.9%
Q2 24
3.2%
-481.3%
Q1 24
-5.3%
-201.4%
EPS (diluted)
III
III
PACB
PACB
Q4 25
$0.06
$-0.11
Q3 25
$0.06
$-0.13
Q2 25
$0.04
$-0.14
Q1 25
$0.03
$-1.44
Q4 24
$0.07
$-0.44
Q3 24
$0.02
$-0.22
Q2 24
$0.04
$-0.64
Q1 24
$-0.07
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
III
III
PACB
PACB
Cash + ST InvestmentsLiquidity on hand
$28.7M
$279.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$94.7M
$5.3M
Total Assets
$211.0M
$784.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
III
III
PACB
PACB
Q4 25
$28.7M
$279.5M
Q3 25
$28.7M
$298.7M
Q2 25
$25.2M
$314.7M
Q1 25
$20.1M
$343.1M
Q4 24
$23.1M
$389.9M
Q3 24
$9.7M
$471.1M
Q2 24
$11.8M
$509.8M
Q1 24
$14.0M
$561.9M
Stockholders' Equity
III
III
PACB
PACB
Q4 25
$94.7M
$5.3M
Q3 25
$94.7M
$36.1M
Q2 25
$94.1M
$61.5M
Q1 25
$95.0M
$91.6M
Q4 24
$96.3M
$506.6M
Q3 24
$96.6M
$453.1M
Q2 24
$95.5M
$492.7M
Q1 24
$95.6M
$649.0M
Total Assets
III
III
PACB
PACB
Q4 25
$211.0M
$784.1M
Q3 25
$213.3M
$803.2M
Q2 25
$200.7M
$825.5M
Q1 25
$202.4M
$860.8M
Q4 24
$204.5M
$1.3B
Q3 24
$227.1M
$1.5B
Q2 24
$235.3M
$1.5B
Q1 24
$234.2M
$1.7B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
III
III
PACB
PACB
Operating Cash FlowLast quarter
$5.1M
$-19.1M
Free Cash FlowOCF − Capex
$4.3M
$-19.9M
FCF MarginFCF / Revenue
7.0%
-44.6%
Capex IntensityCapex / Revenue
1.2%
1.9%
Cash ConversionOCF / Net Profit
1.94×
TTM Free Cash FlowTrailing 4 quarters
$25.0M
$-114.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
III
III
PACB
PACB
Q4 25
$5.1M
$-19.1M
Q3 25
$11.1M
$-18.7M
Q2 25
$11.9M
$-29.4M
Q1 25
$978.0K
$-44.1M
Q4 24
$6.6M
$-30.6M
Q3 24
$8.8M
$-45.5M
Q2 24
$2.2M
$-54.3M
Q1 24
$2.3M
$-75.7M
Free Cash Flow
III
III
PACB
PACB
Q4 25
$4.3M
$-19.9M
Q3 25
$9.5M
$-18.8M
Q2 25
$11.1M
$-29.9M
Q1 25
$141.0K
$-45.4M
Q4 24
$6.0M
$-32.3M
Q3 24
$8.4M
$-46.3M
Q2 24
$1.3M
$-55.7M
Q1 24
$1.3M
$-79.6M
FCF Margin
III
III
PACB
PACB
Q4 25
7.0%
-44.6%
Q3 25
15.2%
-48.9%
Q2 25
18.0%
-75.3%
Q1 25
0.2%
-122.3%
Q4 24
10.4%
-82.3%
Q3 24
13.7%
-115.7%
Q2 24
2.0%
-154.8%
Q1 24
2.0%
-205.0%
Capex Intensity
III
III
PACB
PACB
Q4 25
1.2%
1.9%
Q3 25
2.5%
0.2%
Q2 25
1.4%
1.4%
Q1 25
1.4%
3.7%
Q4 24
0.9%
4.1%
Q3 24
0.6%
2.0%
Q2 24
1.4%
4.1%
Q1 24
1.6%
10.0%
Cash Conversion
III
III
PACB
PACB
Q4 25
1.94×
Q3 25
3.62×
Q2 25
5.46×
Q1 25
0.66×
Q4 24
2.15×
-12.93×
Q3 24
7.66×
Q2 24
1.07×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

III
III

Segment breakdown not available.

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

Related Comparisons